Preventing hysterectomies for dysfunctional uterine bleeding with the HTA™: A survival analysis

Abstract

A questionnaire was sent to 121 women with dysfunctional uterine bleeding who had been treated with the HTA™. Prior to treatment the women had received advice about the failure rate of the HTA™. There was a 68% (82) response rate, of which 11% (9/82) of patients had a hysterectomy. Of these patients 7.3% (6/82) were performed for persistent pelvic pain and 1.2% (1/82) for irregular vaginal bleeding. The projected Kaplan-Meier survival rate for the device over a 5-year period was 89%. The amenorrhoea rate was 42.7% and the oligomenorrhoea rate was 81.7%. The HTA™ is an effective form of treatment for DUB and the majority of women are likely to avoid a hysterectomy at 5 years. © 2006 Springer-Verlag.